Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Padilla

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
Mammographic density and candidate gene variants: a twins and sisters studyJennifer Stone, Lyle C Gurrin, Graham B Byrnes, et al.
International Journal of Cancer|December 1, 2006
5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopeciaVanessa M Hayes, Gianluca Severi, Emma J D Padilla, et al.
Molecular and Cellular Endocrinology|December 23, 2008
HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancerKrishan K Rasiah, Margaret Gardiner-Garden, Emma J D Padilla, et al.
BJU International|November 8, 2007
The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levelsGianluca Severi, Vanessa M Hayes, Andrea A Tesoriero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2006
Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSAGianluca Severi, Vanessa M Hayes, Petra Neufing, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
Mammographic density and candidate gene variants: a twins and sisters studyJennifer Stone, Lyle C Gurrin, Graham B Byrnes, et al.
International Journal of Cancer|December 1, 2006
5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopeciaVanessa M Hayes, Gianluca Severi, Emma J D Padilla, et al.
Molecular and Cellular Endocrinology|December 23, 2008
HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancerKrishan K Rasiah, Margaret Gardiner-Garden, Emma J D Padilla, et al.
BJU International|November 8, 2007
The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levelsGianluca Severi, Vanessa M Hayes, Andrea A Tesoriero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2006
Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSAGianluca Severi, Vanessa M Hayes, Petra Neufing, et al.
Pageof 2